Best Pharma Stocks Based on Machine Learning: Returns up to 20.63% in 3 Days
Package Name: Pharma Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Days (6/14/22 - 6/17/22)
I Know First Average: 4.75%
Read The Full Forecast
Package Name: Pharma Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Days (6/14/22 - 6/17/22)
I Know First Average: 4.75%
Best Biotech Stocks Based on Pattern Recognition: Returns up to 72.42% in 7 Days
Package Name: Biotech Stocks ForecastRecommended Positions: Long
Forecast Length: 7 Days (6/7/22 - 6/14/22)
I Know First Average: 11.66%
Read The Full Forecast
Pharma Stocks Based on Predictive Analytics: Returns up to 26.05% in 7 Days
Package Name: Pharma Stocks ForecastRecommended Positions: Long
Forecast Length: 7 Days (6/7/22 - 6/14/22)
I Know First Average: 5.99%
Read The Full Forecast
Pharma Stocks Based on Stock Algorithm: Returns up to 54.69% in 3 Days
Package Name: Pharma Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Days (6/6/22 - 6/9/22)
I Know First Average: 13.87%
Read The Full Forecast
Top Biotech Stocks Based on Deep-Learning: Returns up to 33.76% in 7 Days
Package Name: Biotech Stocks ForecastRecommended Positions: Long
Forecast Length: 7 Days (6/2/22 - 6/9/22)
I Know First Average: 14.27%
Read The Full Forecast
Best Pharma Stocks Based on Deep Learning: Returns up to 64.72% in 7 Days
Package Name: Pharma Stocks ForecastRecommended Positions: Long
Forecast Length: 7 Days (6/2/22 - 6/9/22)
I Know First Average: 14.3%
Read The Full Forecast
Biotech Stocks Based on Predictive Analytics: Returns up to 73.46% in 3 Days
Package Name: Biotech Stocks ForecastRecommended Positions: Long
Forecast Length: 3 Days (6/5/22 - 6/8/22)
I Know First Average: 17.96%
Read The Full Forecast
Geneva WealthTech Awards Winner
Fintech Technology for Investment Competition Winner
We Are UBS Regional Finalist
I Know First is a WealthTech100 Company
We Are A FinTech Awards Finalist
Start Algorithmic Trading Today!
Gold & Commodity Forecasts
Currency Forecasts
Subscribe To The I Know First Newsletter
